Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells

The design and development of a small molecule named NPB [3-{(4(2,3-dichlorophenyl)piperazin-1-yl}{2-hydroxyphenyl)methyl}-N-cyclopentylbenzamide], which specifically inhibited the phosphorylation of BAD at Ser99 in human carcinoma cells has been previously reported. Herein, the synthesis, character...

Descripción completa

Detalles Bibliográficos
Autores principales: Girimanchanaika, Swamy Savvemala, Dukanya, Dukanya, Swamynayaka, Ananda, Govindachar, Divya Maldepalli, Madegowda, Mahendra, Periyasamy, Ganga, Rangappa, Kanchugarakoppal Subbegowda, Pandey, Vijay, Lobie, Peter E., Basappa, Basappa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540132/
https://www.ncbi.nlm.nih.gov/pubmed/34681659
http://dx.doi.org/10.3390/ijms222011002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540132/
https://www.ncbi.nlm.nih.gov/pubmed/34681659
http://dx.doi.org/10.3390/ijms222011002

Ejemplares similares